Skip to content Skip to footer
Subscribe Now
TOP 20

Top 20 Diagnostics Companies of 2026

Shots:  The global diagnostics market is rapidly evolving through AI-powered imaging, molecular testing, precision medicine, and digital pathology solutions. In 2025, Siemens Healthineers led the industry with $20.54B in diagnostics revenue, followed by Roche at $17.52B and GE HealthCare at $17.49B, reflecting the growing adoption of advanced imaging, lab automation, and AI-driven diagnostics across global…
May 29, 2026

Read more

NEWS

Thermo Fisher Scientific to Divest Microbiology Unit to Astorg for ~$1.08B

Shots: Thermo Fisher Scientific has agreed to sell its microbiology business to Astorg for ~$1.075B, incl. cash & a $50M seller note, as part of its portfolio optimization strategy The divested unit, which offers antimicrobial susceptibility testing and culture media solutions, generated $645M in revenue in 2025 and operates within Thermo Fisher’s Specialty Diagnostics segment…
April 28, 2026

Read more

TOP 20

Top 20 Life Sciences Deals of 2025 

Shots:  From AI-powered discovery to next-generation biologics and gene editing, 2025 was a blockbuster year for life sciences dealmaking. Pharma and biotech companies signed multibillion-dollar partnerships and acquisitions to accelerate innovation across oncology, cardiometabolic diseases, neurology, and rare disorders.  Platform technologies dominated the deal landscape, with big pharma securing access to cutting-edge modalities from bispecific…
March 20, 2026

Read more

TOP 20

Top 20 Diagnostics Companies of 2025 

Top 20 Diagnostics Companies of 2025  Shots:  Driven by continuous innovation and enhanced precision, the diagnostic industry is advancing rapidly, transforming the way healthcare is delivered  In 2025, the global diagnostic testing market is valued at approximately $207.96B in 2025 and is projected to grow to around $272.9B by 2034, reflecting a CAGR of 3%.…
May 29, 2025

Read more

Solventum
NEWS

Thermo Fisher Scientific to Acquire Solventum’s Purification & Filtration Business for ~$4.1B

Shots: Thermo Fisher has entered into definitive agreement with Solventum to acquire its purification & filtration business for ~$4.1B in cash, adding value to its upstream and downstream biologics development & manufacturing Transaction is expected to close by the end of 2025, pending regulatory approval & customary closing conditions Solventum's purification and filtration unit…
February 26, 2025

Read more

Viewpoints_Dino Kazanis_James C. Swartz
VIEWPOINTS

Inspiring Innovations: Dino Kazanis and James Swartz in a Stimulating Conversation with PharmaShots

Shots:  Thermo Fisher Scientific has recently signed a distribution agreement with Labguru to accelerate research and drive scientific breakthroughs. This collaboration integrates Labguru’s state-of-the-art Electronic Lab Notebook (ELN) with Thermo Fisher Scientific’s comprehensive suite of Laboratory Information Management Systems (LIMS) and lab operations software solutions.  By combining ELN and LIMS tools, the partnership aims to…
December 11, 2024

Read more

Viewpoints_Xochitl Javier
VIEWPOINTS

Redefining Technology: Xochitl Javier from Thermo Fisher Scientific in Conversation with PharmaShots

Shots:  Raman Analyzers are widely used in the biopharma industry to analyze different substances. Based on the principles of Raman Spectroscopy, Raman Analyzers provide information about their chemical composition and structure when interacting with laser  Today, at PharmaShots, we have Xochitl Javier, Director, Product Management & Marketing, Thermo Fisher Scientific, shedding light on the TruScan…
July 8, 2024

Read more

VIEWPOINTS_Kylen Cieslak1_Robert Ley2_2023
VIEWPOINTS

Kylen Cieslak and Robert Ley Discuss the Expansion of Thermo Fisher Scientific’s Services Central in the US & EU

Shots:  Kylen Cieslak, Senior Manager, Service Marketing, Thermo Fisher Scientific, and Robert Ley, Senior Strategic Product Manager, Thermo Fisher Scientific in a stirring conversation with PharmaShots   Kylen and Robert highlighted the recent expansion of Thermo Fisher Scientific’s Services Central in the United States and Europe   Services Central is an online platform intended to provide 24/7…
December 7, 2023

Read more

VIEWPOINTS_Betty Woo_2023
VIEWPOINTS

In an Insightful Conversation with PharmaShots, Betty Woo Highlights Thermo Fisher’s Cell Therapy Collaboration Program

Shots:   Betty Woo, VP of Cell, Gene, and Advanced Therapies, Thermo Fisher Scientific discusses the evolution of ThermoFisher’s strategic collaboration with ArsenalBio    Betty highlights the development of programmable autologous T cells for the treatment of cancer and the cell therapy collaboration program   Betty believes that through innovation and partnership, they can tap into the full…
November 30, 2023

Read more